Diabetes Mellitus and Its Correlates in an Iranian Adult Population by Golozar, Asieh et al.
Diabetes Mellitus and Its Correlates in an Iranian Adult
Population
Asieh Golozar
1,2., Hooman Khademi
1., Farin Kamangar
1,2,3, Hossein Poutschi
1, Farhad Islami
1,4,
Christian C. Abnet
2, Neal D. Freedman
2, Philip R. Taylor
2, Paul Pharoah
5, Paolo Boffetta
6,7, Paul J.
Brennan
4, Sanford M. Dawsey
2, Reza Malekzadeh
1, Arash Etemadi
1,2*
1Digestive Disease Research Institute, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran, 2Division of Cancer Epidemiology and Genetics, National
Cancer Institute, Bethesda, Maryland, United States of America, 3Department of Public Health Analysis, School of Community Health and Policy, Morgan State University,
Baltimore, Maryland, United States of America, 4International Agency for Research on Cancer, Lyon, France, 5Cancer Research UK, Department of Oncology, Cambridge
University, Cambridge, United Kingdom, 6The Tisch Cancer Institute, Mount Sinai School of Medicine and Institute for Translational Epidemiology, New York, New York,
United States of America, 7International Prevention Research Institute, Lyon, France
Abstract
The rising epidemic of diabetes imposes a substantial economic burden on the Middle East. Using baseline data from a
population based cohort study, we aimed to identify the correlates of diabetes mellitus (DM) in a mainly rural population
from Iran. Between 2004 and 2007, 50044 adults between 30 and 87 years old from Golestan Province located in Northeast
Iran were enrolled in the Golestan Cohort Study. Demographic and health-related information was collected using
questionnaires. Individuals’ body sizes at ages 15 and 30 were assessed by validated pictograms ranging from 1 (very lean)
to 7 in men and 9 in women. DM diagnosis was based on the self-report of a physician’s diagnosis. The accuracy of self-
reported DM was evaluated in a subcohort of 3811 individuals using fasting plasma glucose level and medical records.
Poisson regression with robust variance estimator was used to estimate prevalence ratios (PR’s). The prevalence of self-
reported DM standardized to the national and world population was 5.7% and 6.2%, respectively. Self-reported DM had
61.5% sensitivity and 97.6% specificity. Socioeconomic status was inversely associated with DM prevalence. Green tea and
opium consumption increased the prevalence of DM. Obesity at all ages and extreme leanness in childhood increased
diabetes prevalence. Being obese throughout life doubled DM prevalence in women (PR: 2.1; 95% CI: 1.8, 2.4). These
findings emphasize the importance of improving DM awareness, improving general living conditions, and early lifestyle
modifications in diabetes prevention.
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Introduction
Chronic diseases, including diabetes mellitus (DM), have
replaced infectious diseases as the main causes of morbidity
and mortality in the developing world [1,2]. Seventy percent of
diabetics in 2010 lived in low- and middle-income countries, and
the greatest relative increase in the burden of DM is expected to
occur in Africa and the Middle East, an approaching epidemic
warranting further study [3–5].
In Iran, the prevalence of DM adjusted for the world population
was predicted to reach 8% in 2010 [5], and the total health
expenditure for DM in 2010 was estimated to be approximately
600 million US dollars [6]. As in other parts of the world, obesity
has been the most consistent risk factor for DM in studies
conducted in Iran [7,8]. Most of these studies, however, have been
conducted in large metropolitan areas. Substantial differences
between urban and rural populations exist in Iran, particularly in
terms of ethnicity, socio-economic status (SES), and habits. As
such, previous observations in urban populations may not apply to
rural areas.
Golestan Province is a largely rural province located in north-
eastern Iran. The prevalence of obesity in Golestan is higher than
in most other parts of Iran and many high-income countries [9].
Golestan also lags behind some other parts of Iran in terms of its
economic and lifestyle development, so studies in Golestan provide
an opportunity to assess disease etiologies in a population in the
early stages of economic transition.
Golestan Province has attracted scientific attention mostly
because of its very high rates of esophageal cancer [10]. Between
2004 and 2007, 50044 Golestan adults (including almost 40000
rural residents) were enrolled in the Golestan Cohort Study (GCS),
which was primarily designed to investigate risk factors for
esophageal cancer. Baseline data from this cohort, gave us the
opportunity to perform a cross-sectional evaluation of obesity and
other less-studied risk factors for diabetes in this mainly rural
population.
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The design of the GCS has been described before [11]. Briefly,
the GCS is a prospective population-based cohort study, launched
in January 2004, which has recruited 50044 adults between 30 and
87 years old from Golestan Province.
Using systematic clustering based on household numbers, a total
of 39399 individuals from 326 rural villages and 10645 urban
residents were enrolled. Demographics and baseline information
including age, sex, education, ethnicity, place of residence,
number of owned household appliances, and history of tobacco
and opium use were collected using a structured lifestyle
questionnaire. Anthropometric data were measured and samples
of blood, urine, hair and nails were gathered from the participants
by a trained technician after the interview.
Education (highest level attained) and appliance ownership,
including bath in the residence, personal car, motorbike, black and
white TV, color TV, refrigerator, freezer, vacuum cleaner and
washing machine, were used as indicators of SES. Using multiple
correspondence analysis, we created a wealth score based on the
appliance ownership variables. These scores were calculated and
participants were categorized into wealth score quartiles [12].
Given the lifestyle of this mainly rural population, most of the
activities individuals have are at work. As a result, only physical
activity at work was looked at in this analysis. Two questions were
asked about individuals’ work activity: if the person worked every
month throughout the year, and if intense physical activity was
part of the daily work. Three levels of occupational physical
activity were defined based on the answers to these questions:
intense physical activity at work, non-intense but regular physical
activity and non-intense irregular physical activity.
Individuals were considered tobacco users if they had smoked
cigarettes or had used nass, hookah or a pipe at least once a week
for a period of 6 months or more. Individuals were categorized
into these groups: never smokers, former cigarette smokers,
current cigarette smokers, and those who smoked other forms of
tobacco (nass, hookah, or a pipe). Current cigarette smokers were
further divided into light and heavy smokers if they fell below or
above the median pack years for the nondiabetic smokers.
Likewise, opium users were defined as those who consumed
opium at least once a week for 6 months or more. The self-
reported use of opium is a reliable and valid indicator of opium
exposure in this population [13].
Systolic and diastolic blood pressures were measured twice in
each arm in the sitting position and averaged. Participants were
considered as being hypertensive if they either reported a phy-
sician’s diagnosis of hypertension, were using anti-hypertensive
medication, or fulfilled the criteria of the Joint National Com-
mittee on Prevention, Detection, Evaluation, and Treatment of
High Blood Pressure (JNC-7) (average systolic blood pressure
above $140 mmHg, or average diastolic blood pressure above
$90 mmHg) [14]. DM was self-reported based on this question:
‘‘Have you ever been diagnosed by a doctor as having diabetes
mellitus?’’.
Green tea consumption was categorized based on both the
frequency and amount of drinking. Non-drinkers did not drink
green tea at all, occasional green tea drinkers drank it less than
once a week, and frequent drinkers drank it at least once a week,
but not every day. Those who drank green tea every day were
divided into low and high intake groups based on whether they
drank less or more than the median (600 ml), respectively. Black
tea consumption was divided into quartiles based on average daily
drinking, since there were very few people who didn’t drink black
tea every day.
Oral health status was summarized using the sum of the number
of decayed, missing, or filled teeth (DMFT), and categorized into 3
levels: ,20, 21–31, and 32.
Body mass index (BMI), as a measure of overall obesity, was
calculated by dividing measured weight (kg) by the square of the
measured height (m), and categorized using the World Health
Organization (WHO) cutoffs: underweight (BMI,18.5 kg/m
2),
normal (18.5#BMI,25 kg/m
2), overweight (25#BMI,30 kg/
m
2), and obese (BMI$30 kg/m
2) [15]. Waist circumference (WC)
was used as a measure of abdominal obesity. Individuals were
categorized as either normal or high risk (WC.102 cm in men
and .88 cm in women) according to the adult treatment panel
(ATP) III criteria [16]. Additionally, participants were also cate-
gorized into quintiles of WC.
Individuals’ body size perceptions at ages 15 and 30 were
assessed using a set of drawings (pictograms), ranging from very
lean to obese. These pictograms were developed by Stunkard et al
[17], and have been shown to have good accuracy for anthropo-
metric assessment in this population [18]. The pictograms were
scoredfrom 1 to 7 inmen, and from 1 to 9 inwomen(Figure 1).The
highest two categories of pictogram score were combined together
due to the relatively small number of observations in these
categories. Obesity was defined as a pictogram score of 5 and
above [17], Change in pictogram score between ages 15 and 30 was
used to assess the association between change in body size during
adulthood and DM. Study participants were categorized into four
categories: no change, decrease, slight increase (a 1 or 2 category
increase) and prominent increase (a more than 2 category increase).
Five years after recruitment, fasting plasma glucose (FPG) level
was measured for a random sample of 3811 cohort participants.
The same baseline questionnaire (including DM self-report) was
again administered at the time of blood draw. Individuals who had
FPG$126 mg/dl (7.0 mmol/l) (the recommended cutoff of the
American Diabetes Association [19]) or were under anti-diabetic
treatment were categorized as having confirmed DM. This
information was used to assess the sensitivity and specificity of
self-reported DM in this study.
The GCS was approved by the Institutional Review Boards of
the Digestive Disease Research Center of Tehran University of
Medical Sciences, the US National Cancer Institute (NCI), and the
World Health Organization International Agency for Research on
Cancer (IARC). All participants gave written informed consent
before enrollment.
Figure 1. Body size pictograms used in the Golestan Cohort
Study.
doi:10.1371/journal.pone.0026725.g001
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The World Standard Population 2000–2005 developed by the
WHO [20] and the 2009 population provided by the Statistical
Center of Iran [21] were used for world and national age-
standardizations, respectively, using the direct age-standardization
method.
We used Poisson regression with robust variance estimator
to get unbiased estimates of prevalence ratios (PR). Poisson
regressions with robust variance estimator are useful alternatives to
log-binomial models; they work equally well when the model is
correctly specified, and are not subject to the convergence
difficulties [22].
Multicollinearity was assessed using the variance inflation factor
(VIF). Aside from obesity-related covariates, no evidence for
serious multicollinearity was observed (all VIFs were below 1.5).
Univariate models were first fitted to assess the independent
association between each covariate and DM. Potential confound-
ers and mediators were identified using a Directed Acyclic Graph
(DAG). Variables included in the DAG were those that have been
consistently reported to be associated with DM, have relevant
biological mechanisms in the disease process, or have been
hypothesized to be associated with DM.
Multivariate models were fitted to assess the direct association
between each of the covariates of interest and diabetes. For age,
the PR was calculated per 10 years increase in age. Since BMI,
WC and pictograms at 15 and 30 years are all measures of obesity,
and also showed high VIF (.2.5), separate models were built for
each to avoid collinearity. Obesity-related covariates were assessed
separately in men and women, but as the effect of BMI on DM
was similar in both sexes, only the pooled effect was reported. All
these models were further adjusted (according to DAG) for age,
ethnicity, place of residence, education and wealth score (2
different indicators of SES), physical activity, tobacco use, opium
use, hypertension, green tea consumption, black tea consumption,
and DMFT score. Another model was built to assess whether
change in body size in early adulthood (between 15 and 30) was
associated with DM risk. Since size at a young age is invariably
correlated with size later in life, we additionally adjusted this
model for body size at 15 years. Finally, the cumulative effect of
obesity since 15 years of age was assessed using the combination of
obesity at 15 and 30 (pictogram score $5) and at the time of
recruitment (BMI$30). Individuals were categorized into 5
groups; never obese, obese at age 15, obese at both ages 15 and
30, obese at age 30 and recruitment, and always obese.
Sensitivity and specificity of self-reported DM were calculated
using the data collected 5 years after recruitment. Confirmed DM
(defined above) was used as a gold standard for this calculation.
All statistical analyses were performed using STATA statistical
software version 11 (Stata Corporation, College Station, TX,
USA). We used hotdeck method to impute the missing values for
variables with more than 50 missing observations. All tests of
hypothesis were conducted at a confidence level of 0.95 under the
two-sided alternative.
Results
The mean age of the cohort participants was 52.1, ranging from
30 to 87 years. 57.6% were female, 74.4% were from Turkmen
ethnicity, 78.7% were rural residents and 70.2% were illiterate.
Of the 50044 individuals recruited into the cohort, 3453
reported having DM at baseline, a crude prevalence of 6.9% (95%
CI: 6.7%, 7.1%). The prevalence standardized to the national and
worldwide population was 5.7% and 6.2%, respectively. Stratified
by ethnicity, the prevalence was 5.9% (95% CI: 5.7%, 6.2%) in
Turkmens and 9.7% (95% CI: 9.2%, 10.3%) in non-Turkmens.
In the subcohort of 3811 participants with available FPG
measurements, the crude prevalence of confirmed DM was 10.9%
(95% CI: 9.9, 11.9) and the prevalence after standardization to the
national and world population was 9.8% and 10.2%, respectively.
The sensitivity and specificity of self-reported DM in this
subcohort were 61.5% and 97.6%, respectively.
Crude and adjusted PR estimates for DM are reported in
Tables 1–4. The adjusted prevalence of diabetes increased 21%
for every 10-year increase in age. The adjusted PRs of DM
associated with non-Turkmen ethnicity and residence in an urban
area were 1.6 (95% CI: 1.5, 1.8) and 1.1 (95% CI: 1.0, 1.2),
respectively. The prevalence of DM was significantly lower in
those with a higher wealth score and higher educational level (P
value for trend ,0.0001).
The prevalence of diabetes was approximately 30% lower in
current smokers than never-smokers (Table 2). Ever-hookah, nass
or pipe smoking was also associated with 32% decrease in the
prevalence of diabetes compared to never-smokers. Opium use
was similar in diabetics and non-diabetics. However, the adjusted
PR of DM associated with opium use was 1.4 (95% CI: 1.3, 1.5).
Hypertension was associated with an 82% increase, and regular
or intense physical activity at work was associated with a 42%
decrease in DM prevalence (Table 2). There was no association
between black tea consumption and diabetes, but green tea
consumption was associated with increased prevalence of diabetes
(P value for trend ,0.0001).
Both BMI and WC were associated with diabetes in this
population (Table 3). The prevalence of DM was 83–95% higher
in overweight and obese people, defined by BMI, and DM
prevalence also increased with increasing WC in both men and
women (P values for trend ,0.0001). Extreme leanness and
obesity during childhood were associated with a significantly
increased prevalence of DM in both sexes (table 4). Additionally,
there was a significant stepwise increase in DM prevalence with
increasing 30 year-old pictogram scores (P values for trend
,0.0001). Increase in body size from 15 to 30 years was also
associated with an increase in the prevalence of DM. Among those
with more than a 2-unit pictogram increase, the PR of DM was
2.3 (95% CI: 1.9, 2.8) in men and 1.8 (95% CI: 1.6, 2.0) in
women. Decrease in body size between these ages had an inverse
association with DM, although the association was statistically
significant only in women (PR: 0.8; 95% CI: 0.7, 1.0).
The cumulative effect of obesity throughout life was different
between men and women. While the strength of associations were
comparable for those who reported being obese at 15 and 30 or at
30 and now in both men and women, being obese throughout life
(at 15, 30 and baseline) was associated with increased DM
prevalence only in women (PR: 2.1; 95% CI: 1.8, 2.4) (Figure 2).
Discussion
In this large population-based study, the overall prevalence of
self-reported diabetes was 6.9%. Some of the most interesting
independent correlates of DM found in this study were ethnicity,
education, wealth score, opium use, consumption of green tea,
body size perception at ages 15 and 30, and change in body size
between 15 and 30 years.
The prevalence of DM in Iran in 2007 was estimated to be
8.7% (95% CI: 7.4%, 10.2%) according to a health survey of 4233
nationally representative Iranians [23]. However, national esti-
mates in other studies varied between 6.1% and 9.8% [5,8,24–27].
The prevalence of self-reported diabetes age-standardized to the
Diabetes in Iran
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than both the national estimates and the estimated prevalence of
confirmed DM in the subcohort. One of the reasons for this low
prevalence of self-reported DM is the people’s lack of awareness of their
condition. It has been reported that one-third to one-half of diabetes
cases are undiagnosed in Iran, so using a self-reported indicator could
be expected to underestimate diabetes prevalence [23,28]. In this
study, only 61.5% of diabetics were aware of their disease.
The rate of self-reported diabetes was significantly less in
Turkmens compared to non-Turkmens (5.9% versus 9.7%) and
such differences persisted even after adjustment for potential
confounders. The predicted prevalence of diabetes in Turkmeni-
stan, north of Golestan, where 77% of the population are
Turkmens, was 6.6% in 2010 [5]. Although this latter estimate
may not be accurate, the similarity between our Golestan Turkmen
rate and the Turkmenistan estimate is consistent with lower rates of
diabetes in this ethnic group. Cultural and ethnic differences in the
perception of illness and in medical-seeking behavior can be other
reasons for these apparently lower prevalence rates.
As indicators of SES, both educational level and wealth score were
inversely associated with DM prevalence. SES inequalities have
been consistently reported to be associated with DM prevalence
[25,29,30]. The association between SES and DM prevalence is
rather complex. While some argue that secondary disability due to
DM complications can lead to diminished ability to work and less
educational opportunities, others attribute this finding to lower
understanding of the disease status, less access to health care, being
more engaged in unhealthy behaviors, and overall having a more
stressful lifestyle in people with low SES [30–32].
Although diabetics have reported less opium use, the prevalence
of self-reported diabetes increased by approximately 1.4 fold in
those using opium compared to non-users. The change in the
direction of the effect of opium was seen when sex, smoking status,
BMI and hypertension were added into the final model. To our
knowledge, this is the first report of a positive association be-
tween opium use and diabetes in a large population-based study.
Although, the possibilities of reverse causation and residual con-
founding cannot be ruled out, it has been shown that opiates can
induce insulin resistance, metabolic syndrome and diabetes [33].
The inverse association seen between smoking and diabetes
prevalence can also be due to reverse causation, and the fact that
sick people tend to seek more medical advice and pursue healthier
lifestyle habits and thus stop smoking.
Several studies have reported a protective effect for tea
consumption on incident diabetes, and the results of a recent
meta-analysis indicated that drinking more than 3–4 cups of tea
(black, green or oolong) per day decreases the risk of DM by 20%
[34]. Despite very high intake of black tea, we did not observe any
significant association for black tea consumption, but we found a
positive association between green tea drinking and diabetes
prevalence. Several animal and human studies have shown an
antidiabetic effect for green tea polyphenols specifically epigallo-
catechin gallate (EGCG) [35–38]. EGCG induces its antidiabetic
effects mostly through reduced hepatic glucose production and
enhanced pancreatic function [37]. Green tea has been shown to
improve glucose tolerance and has been suggested as a
prophylactic agent against diabetes [35]. Our finding can again
be due to reverse causation. Green tea is regarded as an herbal
Table 1. Study Subject Demographics by Self-Reported Diabetes in the Golestan Cohort Study.
Diabetics, N (%) Non-Diabetics, N (%) Crude PR 95% CI Adjusted PR 95% CI
a
3453 (6.9) 46586 (93.1)
Age, mean (SD) 54.6 (8.7) 51.9 (9.0) 1.32
b 1.28, 1.37 1.21
b 1.16, 1.26
Gender, N (%)
Female 2351 (8.2) 26448 (91.8) 1 — 1 —
Male 1102 (5.2) 20138 (94.8) 0.64 0.59, 0.68 0.98 0.89, 1.08
Ethnicity, N (%)
Turkmen 2209 (5.9) 35039 (94.1) 1 — 1 —
Non-Turkmen 1244 (9.7) 11547 (90.3) 1.64 1.53, 1.78 1.59 1.51, 1.82
Residence, N (%)
Rural 2451 (6.2) 36945 (93.8) 1 — 1 —
Urban 1002 (9.4) 9641 (90.6) 1.51 1.41, 1.62 1.08 0.99, 1.18
Wealth score, N (%)
Low 1180 (9.1) 11829 (90.9) 1 — 1 —
Low-Medium 896 (8.3) 11452 (92.7) 0.80 0.74, 0.87 0.88 0.81, 0.96
Medium-High 660 (6.5) 9435 (93.5) 0.72 0.66, 0.79 0.78 0.71, 0.86
High 717 (4.9) 13868 (95.1) 0.54 0.50, 0.59
c 0.63 0.57, 0.70
c
Education, N (%)
Illiterate 2573 (7.3) 32540 (92.7) 1 — 1 —
Up to High School 822 (5.9) 13039 (94.1) 0.81 0.75, 0.87 0.92 0.84, 1.01
Higher Education 58 (5.5) 1006 (94.5) 0.74 0.58, 0.96
c 0.85 0.65, 1.11
c
PR: prevalence ratio, CI: confidence interval, SD: standard deviation.
aVariables included in the model: age, sex, place of residence, race, education, wealth score, physical activity, hypertension, opium, tobacco smoking, green and black
tea consumption, DMFT score, and BMI.
bPR (95% CI) for every 10 year increase in age.
cP-value for trend ,0.0001.
doi:10.1371/journal.pone.0026725.t001
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Thus, diabetics may drink more green tea after their disease has
been diagnosed, due to the common belief in the glucose-lowering
effect of green tea.
Like other reports, we saw a positive association between overall
and abdominal obesity and diabetes prevalence [7,8,28,39]. WC has
been shown to have a high predictive accuracy for diabetes detection
[40], but the predictive accuracy of WC categories based on the ATP
III cut-offs is questionable in developing countries [41,42]. Several
studies have reported lower cut-off points for ‘‘risky’’ WC in
developing countries, and results of a population-based cross-
sectional study of 10522 Iranian adults from Tehran suggested that
compared with the ATP III criteria, optimal cut-off values should be
higher in women and lower in men [43]. To overcome this issue, we
looked at the quintiles of WC as well, and observed a significantly
higher prevalence of diabetes in those in the highest quintile of WC
compared to those in the lowest quintile in both women and men.
In addition to the commonly used measures of obesity, we
were able to investigate the relationship between diabetes and
previously validated pictogram estimates of body size at ages 15
and 30. The significant association seen for the previous 2
measures of obesity and DM was also seen for the pictogram
estimate of body size at the age of 30. The association between
pictogram category at the age of 15 and diabetes was different; the
prevalence of self-reported diabetes increased in those with both
extremes of body size (very lean, and very obese) at the age of 15.
Although information about body size perception at all previous
ages is subject to inaccurate recall, this inverse finding is not
surprising, especially in the developing world. Intra-uterine growth
retardation and subsequent low-birth weight have been shown to be
Table 2. Subject Characteristics by Self-Reported Diabetes in the Golestan Cohort Study.
Diabetics, N (%) Non-Diabetics, N (%) Crude PR 95% CI Adjusted PR 95% CI
a
3453 (6.9) 46586 (93.1)
Tobacco use, N (%)
Never-smoker 2934 (7.5) 36259 (92.5) 1 — 1 —
Former smoker 215 (6.7) 2986 (93.3) 0.90 0.78, 1.02 1.00 0.86, 1.17
Current light smoker 75 (3.3) 2175 (96.7) 0.44 0.36, 0.56 0.70 0.56, 0.88
Current heavy smoker 118 (3.7) 3053 (96.3) 0.50 0.42, 0.60 0.77 0.64, 0.94
Ever-hookah, nass or pipe user 107 (4.9) 2070 (95.1) 0.66 0.55, 0.79
b 0.68 0.56, 0.82
b
Opium use, N (%)
Never-user 2908 (7.0) 38633 (93.0) 1 — 1 —
Ever-user 545 (6.4) 7953 (93.6) 0.92 0.84, 1.00 1.38 1.25, 1.52
Hypertension, N (%)
Normotensive 1210 (4.2) 27417 (95.8) 1 — 1 —
Hypertensive 2230 (10.5) 18967 (89.5) 2.48 2.32, 2.65 1.82 1.70, 1.96
Physical activity at work, N (%)
Irregular non-intense 2492 (8.1) 28177 (91.9) 1 — 1 —
Regular non-intense 774 (5.7) 12846 (94.3) 0.70 0.65, 0.76 0.81 0.75, 0.89
Regular or irregular intense 187 (3.3) 5563 (96.7) 0.40 0.35, 0.46
b 0.58 0.50, 0.68
b
Green Tea, N (%)
None 2712 (6.7) 38044 (93.3) 1 — 1 —
Less than once a week 275 (8.4) 2985 (91.6) 1.29 1.14, 1.45 1.21 1.08, 1.36
Weekly 174 (7.5) 2151 (92.5) 1.13 0.98, 1.31 1.05 0.91, 1.22
Light daily (,600 ml) 133 (8.9) 1358 (91.1) 1.32 1.12, 1.56 1.25 1.06, 1.47
Heavy daily ($600 ml) 127 (9.6) 1193 (90.4) 1.44 1.21, 1.70
b 1.24 1.05, 1.47
b
Black Tea, N (%)
Q1 (#690 ml) 1063 (7.8) 12531 (92.2) 1 — 1 —
Q2 (691–1035 ml) 786 (6.8) 10843 (93.2) 0.90 0.83, 0.98 0.96 0.88, 1.04
Q3 (1036–1500 ml) 765 (6.5) 11090 (93.5) 0.84 0.77, 0.92 0.92 0.84, 1.00
Q4 (.1500 ml) 802 (6.7) 11202 (93.3) 0.85 0.78, 0.93
b 1.02 0.94, 1.12
b
DMFT Categories, N (%)
,20 1006 (6.1) 15447 (93.9) 1 — 1 —
20–32 1113 (6.7) 15464 (93.3) 1.10 1.01, 1.19 1.04 0.96, 1.14
32 1322 (7.8) 15526 (92.2) 1.28 1.19, 1.39
b 1.07 0.98, 1.17
PR: prevalence ratio, CI: confidence interval, DMFT: decayed, missing, or filled teeth.
aVariables included in the model: age, sex, place of residence, race, education, wealth score, physical activity, hypertension, opium, tobacco smoking, green and black
tea consumption, DMFT score, and BMI.
bP-value for trend ,0.0001.
doi:10.1371/journal.pone.0026725.t002
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metabolic disturbances, and obesity later in life [42,44–50]. Our
pictogram findings provide some additional evidence for an inverse
association between childhood body size and later obesity, but they
need to be verified by more accurate measurements of childhood
weight. Similarly, a French cohort study of around 100000 women
born between 1925 and 1950, who had potentially suffered from
food deprivation during World War II, showed an inverse
association between menarche and early adulthood (between 20
and 25) pictogram scores and incident DM [51]. In contrast, the
Nurses’ Health Study II of 100000 women indicated a positive
association between pictograms at ages 5 and 10 and incident type 2
DM [52]. Women in the Nurses’ Health Study II were far less likely
to have suffered from nutritional deficiencies during childhood.
This study has several limitations. First, the cross-sectional nature
of the study makes us unable to establish any temporal relationships.
For example, the associations between smoking, green tea and DM
were some of the findings that can be well explained by reverse
causation. Second, despite the notable agreement between self-report
and medical evidence of diabetes, the self-reported nature of diabetes
assessment could have induced non-differential misclassification
leading to estimates biased towards the null [22,53]. Since most
associations observed in this study were significant, this potential bias
means that some of the effects might actually be stronger than what
we have reported. Finally, recall bias, inherent in cross-sectional
studies,may explain someof the associations observed. Diabetics may
have a different recall of their childhood body size compared to non-
diabetics. However, it has been shown that current body size doesn’t
affect the accuracy of the recall childhood body size [54]. As a result,
any misclassification of childhood obesity would be predominantly
non-differential, and thus, would lead to attenuating the effects of
producing spurious associations.
Some of the advantages of this study are its large sample size,
the opportunity to examine the associations between diabetes and
opium use, black and green tea consumption, information on body
size perception at younger ages, and the ability to assess the link
between these and diabetes. The use of PRs instead of odds ratios
(ORs) was another advantage of this study. PRs are easier to
interpret, and, unlike ORs, are not biased away from the null
[22,55].
In conclusion, we observed low diabetes awareness in this
mainly rural population in Iran. As expected, obesity at all ages
Table 3. Body mass index and Waist Circumference by Self-Reported Diabetes in the Golestan Cohort Study.
Diabetics, N (%) Non-Diabetics, N (%) Crude PR 95% CI Adjusted PR 95% CI
a
3453 (6.9) 46586 (93.1)
Body mass index (BMI), N (%)
Underweight (BMI,18.5) 43 (1.8) 2294 (98.2) 0.49 0.36, 0.67 0.51 0.38, 0.70
Normal (BMI 18.5–24.9) 668 (3.7) 17188 (96.3) 1 — 1 —
Overweight (BMI 25.0–29.9) 1401 (8.3) 15489 (91.7) 2.22 2.03, 2.43 1.83 1.66, 2.01
Obese (BMI$30) 1328 (10.4) 11389 (89.6) 2.77 2.53, 3.03
b 1.95 1.76, 2.16
b
Waist circumference, N (%)
Men
ATP III Criteria
Normal (,102 cm) 549 (3.7) 14387 (96.3) 1 — 1 —
Risky ($102 cm) 552 (8.8) 5747 (91.2) 2.38 2.13, 2.67 2.44 2.17, 2.73
Quintiles
Q1 (,93 cm) 147 (3.0) 4793 (97.0) 1 — 1 —
Q2 (93–96 cm) 155 (4.0) 3741 (96.0) 1.34 1.07, 1.67 1.37 1.09, 1.70
Q3 (97–100 cm) 245 (5.7) 4072 (94.3) 1.91 1.56, 2.33 2.01 1.65, 2.46
Q4 (101–105 cm) 288 (6.7) 3978 (93.3) 2.27 1.87, 2.76 2.46 2.02, 2.98
Q5 (.105) 265 (7.0) 3542 (93.0) 2.34 1.92, 2.85
b 2.61 2.14, 3.19
b
Women
ATP III Criteria
Normal (,88 cm) 204 (2.6) 7601 (97.4) 1 — 1 —
Risky ($88 cm) 2147 (10.2) 18841 (89.8) 3.91 3.40, 4.51 3.90 3.39, 4.49
Quintiles
Q1 (,93 cm) 389 (6.0) 6,085 (94.0) 1 — 1 —
Q2 (93–97 cm) 466 (8.4) 5,109 (91.6) 1.39 1.22, 1.58 1.51 1.33, 1.72
Q3 (98–102 cm) 474 (8.1) 5,411 (91.9) 1.34 1.18, 1.53 1.53 1.35, 1.75
Q4 (103–105 cm) 465 (8.7) 4,853 (91.3) 1.46 1.28, 1.66 1.72 1.51, 1.95
Q5 (.108) 556 (10.0) 4,984 (90.0) 1.67 1.47, 1.89
b 1.98 1.74, 2.24
b
PR: prevalence ratio, CI: confidence interval.
aAll models were adjusted for age, place of residence, race, education, wealth score, physical activity, hypertension, opium, tobacco smoking, green and black tea
consumption, DMFT score. Change in pictogram score between 15 and 30 analysis was further adjusted for pictogram score at 15.
bP value for trend ,0.0001.
doi:10.1371/journal.pone.0026725.t003
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Diabetics, N (%) Non-Diabetics, N (%) Crude PR 95% CI Adjusted PR 95% CI
a
3453 (6.9) 46586 (93.1)
Pictogram at age 15, N (%)
Men
1 (slimmest) 157 (7.3) 2004 (92.7) 1.40 1.16, 1.69 1.35 1.12, 1.63
2 285 (5.2) 5205 (94.8) 1 — 1 —
3 284 (4.4) 6157 (95.6) 0.85 0.72, 1.00 0.87 0.74, 1.02
4 216 (5.3) 3878 (94.7) 1.02 0.86, 1.21 1.08 0.91, 1.28
5 84 (4.4) 1814 (95.6) 0.85 0.67, 1.08 0.95 0.75, 1.20
more than 6 76 (6.6) 1080 (93.4) 1.27 0.99, 1.62 1.34 1.04, 1.72
Women
1 (slimmest) 765 (9.3) 7502 (90.7) 1.31 1.17, 1.47 1.20 1.07, 1.34
2 407 (7.1) 5369 (92.9) 1 — 1 —
3 266 (6.9) 3573 (93.1) 0.98 0.85, 1.14 1.02 0.88, 1.18
4 191 (7.1) 2489 (92.9) 1.01 0.86, 1.19 1.04 0.88, 1.22
5 221 (8.7) 2321 (91.3) 1.23 1.05, 1.44 1.24 1.06, 1.45
6 162 (7.4) 2029 (92.6) 1.05 0.88, 1.25 1.04 0.87, 1.24
7 103 (8.5) 1114 (91.5) 1.20 0.98, 1.48 1.16 0.94, 1.43
more than 8 236 (10.3) 2051 (89.7) 1.46 1.26, 1.71
b 1.32 1.13, 1.55
b
Pictogram at age 30, N (%)
Men
1 (slimmest) 8 (2.7) 291 (97.3) 0.75 0.37,1.52 0.73 0.36, 1.47
2 95 (3.6) 2559 (96.4) 1 — 1 —
3 272 (4.1) 6446 (95.9) 1.13 0.90,1.42 1.08 0.86, 1.35
4 345 (5.0) 6506 (95.0) 1.41 1.13,1.76 1.29 1.03, 1.60
5 245 (7.0) 3234 (93.0) 1.97 1.56,2.48 1.73 1.37, 2.17
more than 6 137 (11.1) 1102 (88.9) 3.09 2.40,3.98
c 2.61 2.03, 3.35
c
Women
1 (slimmest) 91 (5.4) 1585 (94.6) 0.84 0.67,1.05 0.81 0.66, 1.01
2 374 (6.5) 5419 (93.5) 1 — 1 —
3 439 (6.8) 6021 (93.2) 1.05 0.92,1.20 1.05 0.92, 1.20
4 371 (7.3) 4707 (92.7) 1.13 0.99,1.30 1.12 0.98, 1.28
5 366 (8.3) 4027 (91.7) 1.29 1.12,1.48 1.25 1.09, 1.44
6 351 (11.7) 2649 (88.3) 1.81 1.58,2.08 1.71 1.49, 1.97
7 189 (13.6) 1203 (86.4) 2.10 1.78,2.48 1.88 1.59, 2.21
more than 8 170 (16.9) 837 (83.1) 2.61 2.21,3.09
c 2.18 1.84, 2.59
c
Change in Pictogram from 15 to 30, N (%)
Men
No change 213 (3.4) 6121 (96.6) 1 — 1 —
Decrease 101 (3.3) 2955 (96.7) 0.98 0.78, 1.24 0.84 0.65, 1.08
Increase#2 470 (5.7) 7833 (94.3) 1.68 1.44, 1.97 1.55 1.31, 1.83
Increase.2 318 (9.0) 3229 (91.0) 2.67 2.25, 3.16
c 2.31 1.90, 2.81
c
Women
No change 366 (6.4) 5372 (93.6) 1 — 1 —
Decrease 463 (6.5) 6651 (93.5) 1.02 0.89, 1.17 0.82 0.71, 0.95
Increase#2 686 (7.8) 8153 (92.2) 1.22 1.08, 1.38 1.26 1.11, 1.43
Increase.2 836 (11.8) 6272 (88.2) 1.84 1.64, 2.07
c 1.76 1.55, 2.00
c
PR: prevalence ratio, CI: confidence interval.
aAll models were adjusted for age, place of residence, race, education, wealth score, physical activity, hypertension, opium, tobacco smoking, green and black tea
consumption, DMFT score. Change in pictogram score between 15 and 30 analysis was further adjusted for pictogram score at 15.
bP value for trend ,0.01.
cP value for trend ,0.0001.
doi:10.1371/journal.pone.0026725.t004
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ingly extreme leanness in childhood also showed a similar
association. These findings, together with other diabetes correlates
in this population such as low SES and lack of education, show the
importance of improving general living conditions in diabetes
prevention. Decrease in body size from childhood to early
adulthood was associated with lower prevalence of diabetes,
suggesting a potential role for early lifestyle modification in
preventing DM.
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